Nice but ... that guy again? In the whole world can there be more than two doctors (this guy and the one in France) who give us some real data on this?
I agree, if it was that great there should be more doctors speaking out.
COVID-19 Clinical Trial Launches at University of Minnesota. March 17, 2020.
This trial is testing hydroxychloroquine, an FDA-approved medicine for the prevention and treatment of malaria, available since the 1950s and known as Plaquenil. Recent work shows that hydroxychloroquine is active in a laboratory setting against the novel SAS-CoV2 virus, and the trial is designed to see if it translates into benefits for people.FIFTEEN HUNDRED people. That ought to provide some statistically valid results.The trial seeks to enroll up to 1,500 people who have had household contact or those who are healthcare workers that have been exposed to someone with known COVID-19 disease within the past three days and who presently are not ill. The trial is national in scope.
In order to determine if taking the medicine hydroxychloroquine can prevent a person with exposure to the coronavirus from becoming ill or in reducing the severity of illness, the trial will provide hydroxychloroquine to half the study participants, while the other half will receive a vitamin.
To be eligible, one must live with someone who has diagnosed coronavirus COVID-19 or be a healthcare worker with a high-risk exposure within the past three days. The research study medicine will be delivered to their home overnight. If you think you may be eligible to participate in the trial, please email covid19@umn.edu for further instructions.
The trial is being limited to only high-risk exposures, so that the trial may be completed as quickly as possible with the fewest number of volunteers. At this time, people who may have been exposed to coronavirus in the community are currently not eligible to participate.
This is a first clinical trial to determine if this medicine is effective in preventing COVID-19 disease in humans. The trial is led by David Boulware, MD, MPH, a professor of Medicine in the Division of Infectious Diseases, with a collaborative team from throughout the University including infectious disease faculty physicians, biostatisticians, pharmacologists and students. The U of M is funding the trial.
“If effective, this may become a worldwide standard of care for helping prevent disease in other healthcare workers and people exposed,” Boulware said. “Hydroxychloroquine is an off-patent, generic medicine that is inexpensive. A five-day treatment course would cost approximately $12.”
Dr. William Grace ... Lennox Hill in NYC... was on Fox several times ... 100 patients, no death a couple weeks ago.
Malaria drugs touted by Trump can work against coronavirus, top doc tells Laura Ingraham
Ping
There is. A team of Chinese doctors and South Korean doctors published before anyone else. There have been other American doctors who have reported good results, but they are ignored by the mainsteram media. Research that back up these findings started as far back as 2015. The evidence is there, but it is deliberately being ignored.